Answer
Its licence is for use with dexamethasone and sometimes daratumumab or lenalidomide. These treatments act in complementary ways against previously treated multiple myeloma.
Sources for this answer
- Kyprolis — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.